Premium
Compass Therapeutics Inc (CMPX)
NASDAQ
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, develops antibody-based therapeutics for the treatment of various human diseases in the United States. The company’s lead product candidate, tovecimig, is a bispecific antibody that targets delta-like ligand 4 (... Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, develops antibody-based therapeutics for the treatment of various human diseases in the United States. The company’s lead product candidate, tovecimig, is a bispecific antibody that targets delta-like ligand 4 (DLL4) and vascular endothelial growth factor A (VEGF-A), which are critical to angiogenesis and tumor vascularization. It also develops CTX-471, an IgG4 monoclonal antibody that is an agonist of CD137, a key co-stimulatory receptor on immune cells; CTX-8371, a bispecific inhibitor that targets programmed cell death protein-1 (PD-1) and ligand PD-L1 checkpoint inhibitor antibodies; and CTX-10726, a bispecific antibody that targets PD-1 and VEFG-A. The company was founded in 2014 and is headquartered in Boston, Massachusetts. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.41 | -16.8724279835 | 2.43 | 2.47 | 2 | 4981021 | 2.19663519 | CS |
| 4 | 0.22 | 12.2222222222 | 1.8 | 2.47 | 1.75 | 5157106 | 2.04196571 | CS |
| 12 | -3.25 | -61.669829222 | 5.27 | 6.845 | 1.5 | 7969101 | 2.47767697 | CS |
| 26 | -3.57 | -63.8640429338 | 5.59 | 6.88 | 1.5 | 4875155 | 3.24063126 | CS |
| 52 | -0.16 | -7.33944954128 | 2.18 | 6.88 | 1.5 | 3156870 | 3.36390933 | CS |
| 156 | -0.91 | -31.0580204778 | 2.93 | 6.88 | 0.765 | 1499968 | 2.97472489 | CS |
| 260 | -2.08 | -50.7317073171 | 4.1 | 6.88 | 0.765 | 1014028 | 2.99129743 | CS |
Transactions différées
Pour obtenir des transactions en temps réel, améliorez votre compte
Passer à la version en temps réel| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
